Lipella Pharmaceuticals, Inc.   Report issue

For profit Phase 2
Founded: Pittsburgh PA United States (2005)
Status: No NME R&D (2005)

Organization Overview

First Clinical Trial
2015
NCT01393223
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

Lipella Pharmaceuticals, Inc.